Skip to main content
Clinical Trials/CTRI/2020/01/022912
CTRI/2020/01/022912
Recruiting
Phase 2

A randomized controlled clinical study to evaluate the role of Dadimadi Avaleha as palliative care of Sickle cell anaemia in children

Department of Kaumarbhritya0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Kaumarbhritya
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Department of Kaumarbhritya

Eligibility Criteria

Inclusion Criteria

  • 1 Age between 3yrs to 16 yrs irrespective of gender.
  • 2 Hb \>6\.5% and \<11\.5%.
  • 3 Pre diagnosed cases will be taken.
  • 4 Patients with positive sickling test.
  • 5 Patients with sign and symptoms of Sickle cell Anaemia like pallor, fatique, pain, loss of appetite etc.

Exclusion Criteria

  • 1 Age less than 3yrs and greater than 16 yrs.
  • 2 Hb \<6\.5% and \>11\.5%.
  • 3 SCA associated with other disease like Diabetes Mellitus, Hypertension, Thalassemia.

Outcomes

Primary Outcomes

Not specified

Similar Trials